These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Deletions within its subcellular targeting domain enhance the axon protective capacity of Nmnat2 in vivo. Milde S; Fox AN; Freeman MR; Coleman MP Sci Rep; 2013; 3():2567. PubMed ID: 23995269 [TBL] [Abstract][Full Text] [Related]
10. NMNAT2: An important metabolic enzyme affecting the disease progression. Li W; Gao M; Hu C; Chen X; Zhou Y Biomed Pharmacother; 2023 Feb; 158():114143. PubMed ID: 36528916 [TBL] [Abstract][Full Text] [Related]
11. Maintaining energy homeostasis is an essential component of Wld(S)-mediated axon protection. Shen H; Hyrc KL; Goldberg MP Neurobiol Dis; 2013 Nov; 59():69-79. PubMed ID: 23892229 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration. Loreto A; Hill CS; Hewitt VL; Orsomando G; Angeletti C; Gilley J; Lucci C; Sanchez-Martinez A; Whitworth AJ; Conforti L; Dajas-Bailador F; Coleman MP Neurobiol Dis; 2020 Feb; 134():104678. PubMed ID: 31740269 [TBL] [Abstract][Full Text] [Related]